Major Japanese Drug Makers Jointly Apply For Additional Indications For H. Pylori Combo Therapy
This article was originally published in PharmAsia News
Executive Summary
Nine Japanese drug makers of proton pump inhibitors and antibiotic drugs Oct. 1 jointly applied for additional indications for combination therapy of the agents to eradicate helicobacter pylori